NIH scientists reflect on gains in emerging infectious disease awareness, research and response

In a new essay, National Institute of Allergy and Infectious Diseases director Anthony S. Fauci, M.D., and David Morens, M.D., reflect on what has been learned about emerging infectious diseases (EIDs) in the two decades since a major report from the U.S. Institute of Medicine rekindled interest in this important topic.

Heightened awareness of EIDs is itself a countermeasure against disease, note the authors. The emergence of new diseases can now be monitored in real time online through Internet resources such as ProMED. In 2012 alone, such resources kept the scientific community and the public informed about the emergence in the Middle East of a novel disease-causing coronavirus; occurrences of illness at caused by a hantavirus; and the emergence in U.S. farm communities of a variant (H3N2v) that spread from swine to people. The authors point to advances that have improved the diagnosis, treatment and prevention of EIDs. Rapid sequencing of whole genomes, for example, allows for swift identification of new disease agents. The complex interactions between disease-causing microbes and human hosts are being revealed through approaches that describe entire biological systems holistically (). The data from such studies can be used to inform the development of drugs or vaccines. Recent appreciation of the sometimes beneficial role of communities of microorganisms dwelling in the gut, mouth, skin and other niches has reshaped the standard notion of infectious diseases as a simple contest between virulent invading pathogens and the .

The scientists emphasize the need for sustained commitment to developing countermeasures for specific diseases and to basic research that will lead to a greater understanding of infectious diseases and human susceptibility.

More information: DM Morens and AS Fauci. Emerging infectious diseases in 2012: 20 years after the Institute of Medicine report. mBio DOI: 10.1128/mBio.00494-12 (2012) (http://mbio.asm.org/content/3/6/e00494-12).

add to favorites email to friend print save as pdf

Related Stories

NIAID scientists consider 200 years of infectious diseases

Feb 02, 2012

Unpredictable, ever-changing and with potentially far-reaching effects on the fates of nations, infectious diseases are compelling actors in the drama of human history, note scientists from the National Institute of Allergy ...

Recommended for you

Where Ebola battles are won

7 hours ago

(HealthDay)—Four hospitals that are home to advanced biocontainment facilities have become America's ground zero in the treatment of Ebola patients.

Depression tied to worse lumbar spine surgery outcomes

9 hours ago

(HealthDay)—Depressive symptoms are associated with poorer long-term outcome in patients undergoing surgery for lumbar spinal stenosis (LSS), according to research published in the Oct. 1 issue of The Sp ...

Ebola death toll edging to 4,900 mark: WHO

10 hours ago

The death toll in the world's worst-ever Ebola outbreak has edged closer to 4,900, while almost 10,000 people have now been infected, new figures from the World Health Organization showed Wednesday.

US to track everyone coming from Ebola nations

10 hours ago

U.S. authorities said Wednesday that everyone traveling into the U.S. from Ebola-stricken nations will be monitored for symptoms for 21 days. That includes returning American aid workers, federal health employees ...

User comments